Clinical trials: Asymptomatic COVID-19
SARS-CoV-2
Evaluation of the COVIDSeq Test in Saliva Specimens From COVID-19 Asymptomatic Illumina Personnel
"This is a prospective, multi-center specimen collection study. Subjects 18 years of age or older who do not have symptoms of COVID-19 will be enrolled.
- Trial name
- NCT04561089
- Testing
- COVIDSeq Test
- Where
- 3 sites in United States
- Volunteers
- 763 people, healthy volunteers welcome
- Sponsor
- Illumina, Inc.
Covid19
Phase 3 Clinical Study Evaluating Nitric Oxide Nasal Spray (NONS) Efficacy To Treat and Prevent the Exacerbation of Infection in Individuals With Documented Asymptomatic or Mild COVID-19
Study Design: This is a double-blind, placebo-controlled, Phase 3 clinical efficacy study evaluating NONS in adult volunteers as a treatment for high-risk asymptomatic and symptomatic individuals with mild COVID-19 infection.
- Trial name
- NCT05012319
- Testing
- to be given as a treatment
- Where
- Bahrain
- Volunteers
- 500 people
- Sponsor
- Salmaniya Medical Complex
Asymptomatic Condition, Healthy
An Approach to Screening for COVID-19 at Vancouver Airport
The primary objective of this pilot study is to determine the feasibility and effectiveness of a COVID-19 screening program for passengers departing from YVR.
- Trial name
- NCT04665193
- Testing
- Rapid Antigen Test
- Where
- Canada
- Volunteers
- 592 people, healthy volunteers welcome
- Sponsor
- University of British Columbia
COVID19, Hydroxychloroquine
Protect: Study With Hydroxychloroquine for Prevention and Early Phase Treatment of Coronavirus Disease (COVID-19)
This is a Italian, superiority, open label cluster-randomised, interventional clinical trial aimed at assessing whether the treatment with Hydroxychloroquine can reduce the percentage of symptomatic subjects compared to…
- Conditions
- COVID19, Hydroxychloroquine, Prophylaxis, Treatment
- Trial name
- PROTECT (NCT04363827)
- Testing
- Hydroxychloroquine
- Where
- Italy
- Volunteers
- 155 people, healthy volunteers welcome
- Sponsor
- Istituto Romagnolo per lo Studio dei Tumori Dino Amadori IRST S.r.l. IRCCS
Covid19, SARS CoV-2
Capturing Infectious COVID-19 Asymptomatic Cases in Singapore
This study is being conducted to assess the performance of the BD Veritor™ Plus System for Rapid Detection of SARS-CoV-2, used in serial testing, in identification of infectious, asymptomatic individuals.
- Trial name
- NCT04812327
- Testing
- BD Veritor Plus System for Rapid Detection of SARS CoV-2, rt-PCR, viral culture
- Where
- Singapore
- Sponsor
- Becton, Dickinson and Company
COVID-19
Wearable Diagnostic for Detection of COVID-19 Infection
The goals of this study are 1) to validate the use of a wearable diagnostic capability and software as a medical device (SaMD) algorithm for the pre or early-symptomatic detection of COVID-19 infection, 2) assess the wearable…
- Trial name
- NCT04742569
- Where
- United States
- Volunteers
- 790 people, healthy volunteers welcome
- Sponsor
- ClinOne, Inc.
Coronavirus Disease 2019(COVID-19)
A Clinical Study to Assess Preliminary Efficacy, Safety and Tolerability of HH-120 Nasal Spray in COVID-19 Patients
To evaluate the preliminary efficacy and safety of HH-120 nasal spray in the treatment of asymptomatic or mild COVID-19.
- Trial name
- NCT05659602
- Testing
- HH-120 Nasal Spray
- Where
- China
- Volunteers
- 111 people
- Sponsor
- Beijing Ditan Hospital
SARS-CoV-2, Influenza A
Clinical Validation of the LumiraDx SARS-CoV-2 & Flu A/B Combo Test
This is a prospective multicenter study conducted to evaluate the performance of the LumiraDx SARS-CoV-2 \& Flu A/B tests at point of care sites.
- Conditions
- SARS-CoV-2, Influenza A, Influenza B, Asymptomatic COVID-19
- Trial name
- ITAP1489 (NCT05787444)
- Testing
- LumiraDx SARS-CoV-2 & Flu A/B
- Where
- United States
- Volunteers
- 1,081 people
- Sponsor
- LumiraDx UK Limited
Covid19
Efficacy of Psidii Guava's Extract For COVID-19
This study was an experimental, randomized clinical trial, with a parallel design, with aims were seeing the effectiveness of extracted Psidii guava on white blood cells (WBCs) count, neutrophil, lymphocyte, monocyte…
- Trial name
- NCT04810728
- Testing
- Extract Psidii guava, Standard therapy for Covid-19 patient
- Where
- Indonesia
- Volunteers
- 90 people
- Sponsor
- Baiturrahmah University
COVID 19, Inflammatory Status
FOUND - Ancillary Study to Smile Protocol NCT03654105
During the current pandemic, in Italy the majority of asymptomatic or pauci-symptomatic COVID-19 cases were not identified nor diagnosed and this fact caused a decrease in the effectiveness of the various containment measures…
- Trial name
- FOUND (NCT04441814)
- Where
- Italy
- Volunteers
- 960 people, healthy volunteers welcome
- Sponsor
- Fondazione IRCCS Istituto Nazionale dei Tumori, Milano
Covid19, Coronavirus Infection
Steam Inhalations in COVID-19 Patients
The new coronavirus (SARS-CoV-2) causing COVID-19 is an RNA virus coated with a capsid and a peri-capsid crossed by glycoprotein structures.
- Conditions
- Covid19, Coronavirus Infection, Coronavirus
- Trial name
- Steam-COVID (NCT04743349)
- Testing
- Steam inhalations
- Where
- Italy
- Volunteers
- 143 people
- Sponsor
- Meyer Children's Hospital IRCCS
Covid19, SARS-CoV-2
Asymptomatic SARS-CoV-2 Detection in Children
The primary objective of this study is quantify the transmission risk posted by SARS-CoV-2 in pre/asymptomatic infected children in order to inform the public health response to the COVID-19 pandemic.
- Trial name
- NCT04853316
- Where
- 5 sites in United States, Canada
- Volunteers
- 372 people
- Sponsor
- University of Calgary
COVID-19, SARS-CoV2 Infection
Asymptomatic and Pre-symptomatic Transmission of SARS-CoV-2 in a Community Congregant Setting
The overall aim of this study is to measure how transmission of COVID-19 occurs in communities - including the role of super spreaders and/or identifying conditions that may increase transmission risk, with a focus on congregant…
- Trial name
- NCT05145803
- Testing
- Polyvinylalcohol strip [diagnostic]
- Where
- 6 sites in United States
- Volunteers
- 3,300 people, healthy volunteers welcome
- Sponsor
- Colorado School of Public Health
COVID-19
Serological and PCR Testing for COVID-19
Richmond Research Institute (RRI) is applying existing and new COVID-19 PCR and antibody tests to help develop methodologies which provide fast and accurate results.
- Trial name
- NCT04404062
- Testing
- Membrane-based immunoassay kit, Quantitative antibody Tests, PCR Test
- Where
- United Kingdom
- Volunteers
- 2,500 people, healthy volunteers welcome
- Sponsor
- Richmond Research Institute